IBD Patients Respond Well To Restarting Remicade, According To Study

IBD Patients Respond Well To Restarting Remicade, According To Study
A new study entitled “Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy” published in the journal Clinical Gastroenterology and Hepatology reports the safety and efficacy of reintroducing Infliximab therapy for patients with Crohn’s disease or ulcerative colitis. Inflammatory bowel disease is characterized by chronic inflammation in the digestive tract, and

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *